These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28882471)

  • 21. No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.
    Fan X; Liu E; Freudenreich O; Copeland P; Hayden D; Ghebremichael M; Cohen B; Ongur D; Goff DC; Henderson DC
    J Clin Psychopharmacol; 2013 Apr; 33(2):226-30. PubMed ID: 23422397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
    Boggs DL; Surti T; Gupta A; Gupta S; Niciu M; Pittman B; Schnakenberg Martin AM; Thurnauer H; Davies A; D'Souza DC; Ranganathan M
    Psychopharmacology (Berl); 2018 Jul; 235(7):1923-1932. PubMed ID: 29619533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Event-related potentials P₃₀₀ with memory function and psychopathology in first-episode paranoid schizophrenia].
    Liu WB; Chen QZ; Yin HM; Zheng LL; Yu SH; Chen YP; Li HC
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 40(6):647-52. PubMed ID: 22190526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of sleep and pituitary-adrenal inhibition after subchronic intranasal vasopressin treatment in elderly humans.
    Perras B; Wagner U; Born J; Fehm HL
    J Clin Psychopharmacol; 2003 Feb; 23(1):35-44. PubMed ID: 12544374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial.
    Sepehrmanesh Z; Heidary M; Akasheh N; Akbari H; Heidary M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():289-296. PubMed ID: 29126981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.
    Riedel M; Schennach-Wolff R; Musil R; Dehning S; Cerovecki A; Opgen-Rhein M; Matz J; Seemüller F; Obermeier M; Engel RR; Müller N; Möller HJ; Spellmann I
    Hum Psychopharmacol; 2010 Mar; 25(2):116-25. PubMed ID: 20196179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.
    Keefe RS; Meltzer HA; Dgetluck N; Gawryl M; Koenig G; Moebius HJ; Lombardo I; Hilt DC
    Neuropsychopharmacology; 2015 Dec; 40(13):3053-60. PubMed ID: 26089183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans.
    Guastella AJ; Kenyon AR; Alvares GA; Carson DS; Hickie IB
    Biol Psychiatry; 2010 Jun; 67(12):1220-2. PubMed ID: 20447617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.
    Veselinović T; Scharpenberg M; Heinze M; Cordes J; Mühlbauer B; Juckel G; Habel U; Rüther E; Timm J; Gründer G;
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):720-739. PubMed ID: 30981585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive Raloxifene and Isradipine Improve Cognitive Functioning in Patients With Schizophrenia: A Pilot Study.
    Vahdani B; Armani Kian A; Esmaeilzadeh A; Zenoozian S; Yousefi V; Mazloomzadeh S
    J Clin Psychopharmacol; 2020; 40(5):457-463. PubMed ID: 32796392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlates of cognitive deficits in first episode schizophrenia.
    Heydebrand G; Weiser M; Rabinowitz J; Hoff AL; DeLisi LE; Csernansky JG
    Schizophr Res; 2004 May; 68(1):1-9. PubMed ID: 15037334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
    Bervoets C; Morrens M; Vansteelandt K; Kok F; de Patoul A; Halkin V; Pitsi D; Constant E; Peuskens J; Sabbe B
    CNS Drugs; 2012 Nov; 26(11):975-82. PubMed ID: 23018547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
    Lane HY; Chang YC; Liu YC; Chiu CC; Tsai GE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1196-204. PubMed ID: 16275807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between COMT gene polymorphisms, clinical symptoms, and cognitive functions in Han Chinese patients with schizophrenia.
    Sun Z; Zhang Z; Mao P; Ma Y; Li W; Li J; Yang X; Ling S; Tang Y
    Psychiatr Genet; 2018 Jun; 28(3):47-54. PubMed ID: 29634613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia.
    Feifel D; Macdonald K; Cobb P; Minassian A
    Schizophr Res; 2012 Aug; 139(1-3):207-10. PubMed ID: 22682705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.
    Pietrowsky R; Strüben C; Mölle M; Fehm HL; Born J
    Biol Psychiatry; 1996 Mar; 39(5):332-40. PubMed ID: 8704064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.